4383 Medical Drive
Suite 4077
San Antonio, TX
78229
(210) 593-2514
Shelly Gunn M.D., Ph.D.
Dr. Shelly Gunn is a board certified clinical pathologist in private practice in San Antonio Texas with an office at the START Center for Cancer Care. She graduated with a combined MD/PhD degree from the UTHSCSA Medical School and Graduate School of Biomedical Sciences with a focus in diagnostic molecular genetics, and also completed her clinical pathology residency at UTHSCSA. Dr. Gunn now serves as the Medical Director for Combimatrix Molecular Diagnostics Laboratory (CMDX) based in Irvine, CA and also as assistant clinical professor in the UTHSCSA Department of Pathology. Dr. Gunn is a recipient of the Association for Molecular Pathology’s Young Investigator Award for outstanding translational research and she has published numerous papers and abstracts related to developing DNA based genomic evaluation as a clinical test. Her clinical focus is the delivery of personalized cancer care to patients through genetic testing of hematological malignancies and solid tumors, with a specialty in breast cancer genome analysis.
Ryan Robetorye M.D., Ph.D.
Dr. Robetorye is board-certified in Clinical Pathology, Hematology, and Molecular Genetic Pathology. He recently joined the faculty of the Mayo Clinic after serving for six-and-a-half years on the faculty of the Department of Pathology at the University of Texas Health Science Center at San Antonio (UTHSCSA) in San Antonio, Texas. Dr. Robetorye graduated with a combined M.D./Ph.D. degree from Baylor College of Medicine in Houston, Texas. At Baylor, his Ph.D. work focused on the relationship between cellular aging and cancer. He then completed a Clinical Pathology residency and a two-year Hematopathology fellowship at the University of Utah School of Medicine in Salt Lake City, Utah. While at the University of Utah, Dr. Robetorye was the recipient of the University of Utah School of Medicine Department of Pathology’s Resident Research Award, the Association for Molecular Pathology’s Young Investigator Award, the Society for Hematopathology’s Young Investigator Award, and the United States and Canadian Academy of Pathology’s Stowell-Orbison Merit Award. At UTHSCSA, Dr. Robetorye served as the Medical Director of the Molecular Diagnostics Laboratory and the Director of the Cancer Therapy and Research Center’s Microarray Core Laboratory. Dr. Robetorye’s current research interests involve the identification of prognostically important genes and genetic pathways in chronic leukemias and non-Hodgkin lymphomas using microarray technology. He also serves as a clinical consultant for the Combimatrix Molecular Diagnostics Laboratory in Irvine, California.